![Rune Blomhoff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rune Blomhoff
Corporate Officer/Principal at University of Oslo
Rune Blomhoff active positions
Companies | Position | Start | End |
---|---|---|---|
University of Oslo | Corporate Officer/Principal | - | - |
Career history of Rune Blomhoff
Former positions of Rune Blomhoff
Companies | Position | Start | End |
---|---|---|---|
Cgene AS
![]() Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Chairman | 21/04/1985 | - |
Founder | 21/04/1985 | - |
Statistics
International
Norway | 3 |
Operational
Corporate Officer/Principal | 1 |
Chairman | 1 |
Founder | 1 |
Sectoral
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Cgene AS
![]() Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Commercial Services |
- Stock Market
- Insiders
- Rune Blomhoff
- Experience